CytoMed Therapeutics logo
CytoMed Therapeutics
GDTC | NASDAQ
Chart Builder DCF Calculator
$0.77
-$0.06 (-7.15%)
At close: Nov 16, 2026, 4:00 PM ET
$0.77
$0.00 (+0.51%)
After-hours: Nov 16, 2026, 4:00 PM ET

CytoMed Therapeutics Company Profile

Company profile explained

Company Profile

CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.

Key Executives

Name Position
Yvonne Goh Chief Financial Officer
Chee Kong Choo Executive Chairman
Jieming Zeng Chief Scientific & Medical Officer and Director
Tien Wee Luk Chief Clinical Officer
Yoong Ying Tan Chief Corporation Officer

Latest SEC Filings

Date Type Title
Oct 23, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 16, 2026 SC 13D/A [Amend] Filing
Oct 13, 2026 SC 13D/A [Amend] Filing
Oct 13, 2026 6-K Filing
Sep 30, 2026 6-K Filing
Jul 24, 2026 4/A [Amend] Filing
Jul 24, 2026 SC 13D/A [Amend] Filing
Jul 24, 2026 4 Filing
Jun 23, 2026 6-K Filing
Jun 15, 2026 4 Filing
View All SEC Filings ➞
CytoMed Therapeutics
CytoMed Therapeutics logo
Country Singapore
IPO Date Apr 14, 2023
Industry Biotechnology
Sector Healthcare
Employees 42
CEO Chee Kong Choo

Contact Details

1 Commonwealth Lane, No. 08-22 Singapore, CE 149544 Singapore

Stock Details

Ticker Symbol GDTC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001873093
CUSIP Number n/a
ISIN Number SGXZ17669631
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.